Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | |
|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||
| Cash from operating activities | -2.64%1.71B | 56.55%1.75B | 39.86%1.12B | -24.81%801.49M | -16.27%1.07B | 1.27B |
| Net profit before non-cash adjustment | -78.15%70.87M | 52.33%324.32M | -34.18%212.91M | 5,631.31%323.48M | -98.60%5.64M | --404.12M |
| Total adjustment of non-cash items | 7.22%1.71B | 60.45%1.6B | 88.86%996.66M | -44.63%527.73M | 5.75%953.02M | --901.2M |
| -Depreciation and amortization | 20.64%1.82B | 24.80%1.51B | 37.33%1.21B | -11.45%879.14M | 3.63%992.84M | --958.04M |
| -Reversal of impairment losses recognized in profit and loss | --16.25M | --0 | ---- | ---- | --43.26M | ---- |
| -Disposal profit | ---41.58M | --0 | ---- | 1.24%-35.71M | 70.26%-36.16M | ---121.59M |
| -Other non-cash items | -184.00%-77.68M | 143.90%92.47M | 33.28%-210.65M | -572.79%-315.7M | -172.48%-46.92M | --64.74M |
| Changes in working capital | 54.35%-76.96M | -90.32%-168.59M | -78.20%-88.59M | -146.34%-49.71M | 433.08%107.29M | ---32.21M |
| -Change in receivables | 88.02%-17.9M | -112.83%-149.42M | 31.17%-70.21M | -227.27%-102M | 258.01%80.14M | --22.39M |
| -Change in inventory | -215.62%-80.78M | -136.77%-25.6M | -137.35%-10.81M | 304.47%28.95M | 50.66%-14.16M | ---28.69M |
| -Change in payables | 349.84%20.3M | -12,798.41%-8.13M | 93.43%-63K | -106.25%-959K | 293.75%15.36M | ---7.93M |
| -Provision for loans, leases and other losses | -90.20%1.43M | 293.79%14.55M | -132.24%-7.51M | 81.52%23.29M | 717.13%12.83M | --1.57M |
| -Changes in other current assets | ---- | ---- | ---- | -92.25%1.02M | 167.10%13.12M | ---19.55M |
| Dividends paid (cash flow from operating activities) | ||||||
| Dividends received (cash flow from operating activities) | ||||||
| Interest paid (cash flow from operating activities) | -129.21%-39.92M | -45.99%-17.42M | -26.03%-11.93M | 11.11%-9.47M | 25.22%-10.65M | -14.24M |
| Interest received (cash flow from operating activities) | 365.75%340K | 305.56%73K | 350.00%18K | 33.33%4K | 0.00%3K | 3K |
| Tax refund paid | -2,539.33%-187.1M | 96.28%-7.09M | -314.77%-190.72M | 137.94%88.8M | -95.17%-234.08M | -119.94M |
| Other operating cash inflow (outflow) | 0 | 300.00%2K | -200.00%-1K | 0.00%1K | 200.00%1K | -1K |
| Operating cash flow | -14.36%1.48B | 88.43%1.73B | 4.26%918.35M | 7.26%880.83M | -27.90%821.22M | --1.14B |
| Investing cash flow | ||||||
| Net PPE purchase and sale | 3.78%-2.97B | -23.32%-3.09B | -204.77%-2.51B | -1,326.16%-822.47M | 104.88%67.08M | ---1.37B |
| Net intangibles purchase and sale | -24.85%-10.08M | 84.06%-8.07M | -1,421.57%-50.64M | 88.22%-3.33M | -103.12%-28.24M | ---13.9M |
| Net business purchase and sale | --41.58M | --0 | ---- | ---- | ---- | ---- |
| Net changes in other investments | -96.41%-19.48M | -100.75%-9.92M | -392.37%-4.94M | 3.68%1.69M | 348.85%1.63M | ---655K |
| Investing cash flow | 4.72%-2.96B | -21.35%-3.11B | -210.91%-2.56B | -2,136.49%-824.11M | 102.92%40.47M | ---1.39B |
| Financing cash flow | ||||||
| Net issuance payments of debt | 131.08%3.76B | 20.94%1.63B | 501.52%1.34B | 125.51%223.55M | -443.46%-876.24M | --255.12M |
| Net common stock issuance | --0 | -81.16%50.53M | --268.26M | ---- | ---- | ---- |
| Increase or decrease of lease financing | ---- | ---- | ---- | -59.78%-18.02M | 18.36%-11.28M | ---13.81M |
| Cash dividends paid | -0.81%-24.88M | -128.92%-24.68M | ---10.78M | ---- | ---- | ---- |
| Net other fund-raising expenses | 47.16%-8.89M | -3.24%-16.83M | -1,630,000.00%-16.3M | ---1K | ---- | ---1K |
| Financing cash flow | 127.74%3.72B | 3.11%1.64B | 671.59%1.59B | 123.16%205.53M | -467.80%-887.52M | --241.31M |
| Net cash flow | ||||||
| Beginning cash position | 37.96%937.9M | -9.40%679.82M | 53.73%750.35M | -5.03%488.09M | -1.48%513.92M | --521.64M |
| Current changes in cash | 774.74%2.24B | 542.23%256.48M | -122.11%-58M | 1,115.36%262.26M | -234.49%-25.83M | ---7.72M |
| Effect of exchange rate changes | -17.96%1.31M | 112.71%1.59M | ---12.53M | ---- | ---- | ---- |
| Cash adjustments other than cash changes | --2K | ---- | ---- | --1K | ---- | --1K |
| End cash Position | 239.35%3.18B | 37.96%937.9M | -9.40%679.82M | 53.73%750.35M | -5.03%488.09M | --513.92M |
| Free cash flow | -9.09%-1.51B | 18.09%-1.39B | -402.15%-1.69B | -151.48%-336.83M | 254.58%654.34M | ---423.31M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |